Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11684-020-0810-9 http://scihub22266oqcxt.onion/10.1007/s11684-020-0810-9 32761491!7406954!32761491     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Med 2020 ; 14 (5): 664-673 Nephropedia Template TP {{tp|p=32761491|t=2020. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 |pdf=|usr=}}{{32761491}} gab.com Text Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 JO: Front Med http://www.kidney.de/pget.php?&tw=1&pmid=32761491 #FOAvip The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with severe cases of COVID-19. Herein, we describe two confirmed cases of COVID-19 in Wuhan to explore the role of MSC in the treatment of COVID-19. MSC transplantation increases the immune indicators (including CD4 and lymphocytes) and decreases the inflammation indicators (interleukin-6 and C-reactive protein). High-flow nasal cannula can be used as an initial support strategy for patients with ARDS. With MSC transplantation, the fraction of inspired O(2) (FiO(2)) of the two patients gradually decreased while the oxygen saturation (SaO(2)) and partial pressure of oxygen (PO(2)) improved. Additionally, the patients' chest computed tomography showed that bilateral lung exudate lesions were adsorbed after MSC infusion. Results indicated that MSC transplantation provides clinical data on the treatment of COVID-19 and may serve as an alternative method for treating COVID-19, particularly in patients with ARDS. Twit Text FOAVip Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 ????Front Med http://www.kidney.de/pget.php?&tw=1&pmid=32761491 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32761491 #FOAvip English Wikipedia <ref>{{Cite pmid|32761491}}</ref> Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 #MMPMID32761491 Tang L; Jiang Y; Zhu M; Chen L; Zhou X; Zhou C; Ye P; Chen X; Wang B; Xu Z; Zhang Q; Xu X; Gao H; Wu X; Li D; Jiang W; Qu J; Xiang C; Li L Front Med 2020[Oct]; 14 (5): 664-673 PMID32761491show ga The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with severe cases of COVID-19. Herein, we describe two confirmed cases of COVID-19 in Wuhan to explore the role of MSC in the treatment of COVID-19. MSC transplantation increases the immune indicators (including CD4 and lymphocytes) and decreases the inflammation indicators (interleukin-6 and C-reactive protein). High-flow nasal cannula can be used as an initial support strategy for patients with ARDS. With MSC transplantation, the fraction of inspired O(2) (FiO(2)) of the two patients gradually decreased while the oxygen saturation (SaO(2)) and partial pressure of oxygen (PO(2)) improved. Additionally, the patients' chest computed tomography showed that bilateral lung exudate lesions were adsorbed after MSC infusion. Results indicated that MSC transplantation provides clinical data on the treatment of COVID-19 and may serve as an alternative method for treating COVID-19, particularly in patients with ARDS. |*Coronavirus Infections/diagnosis/drug therapy/epidemiology/physiopathology/therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/epidemiology/physiopathology/therapy[MESH] |Adult[MESH] |Aged[MESH] |Betacoronavirus/*isolation & purification[MESH] |Blood Cells/physiology[MESH] |Blood Coagulation Tests/methods[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Testing[MESH] |China[MESH] |Clinical Laboratory Techniques/methods[MESH] |Combined Modality Therapy[MESH] |Critical Care/*methods[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Mesenchymal Stem Cell Transplantation/*methods[MESH] |Monitoring, Immunologic/methods[MESH] |Oximetry/methods[MESH] |Preliminary Data[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH] |Symptom Assessment/methods[MESH]Clinical study using mesenchymal stem cells for the treatment of patie(epmc).pdf DeepDyve Pubget Overpricing